The role of fMRI in drug discovery

作者: Richard G. Wise , Irene Tracey

DOI: 10.1002/JMRI.20584

关键词: Drug developmentNeuroscienceDrug discoveryClinical investigationBiomarker (cell)Human brainMedicinePharmacogeneticsDrug effectDrug action

摘要: Pharmacological functional (phMRI) studies are making a significant contribution to our understanding of drug-effects on brain systems. fMRI has an additional make in the translation disease models and candidate compounds from preclinical clinical investigation early stages drug development. Here it can demonstrate proof-of-concept action small human cohort thus contribute substantially decision-making We review methods underlying pharmacological links that be made between animal investigations. discuss potential markers effect, experimental designs caveats interpreting hemodynamic data as reflective changes neuronal activity. Although there no current published examples applied novel compounds, we illustrate across range applications with specific reference processing pain analgesia. is developing meet neuroscientific challenges. Electrophysiological used corroborate effects measured hemodynamically fMRI. In future, likely extend examinations spinal cord into pharmacogenetics relate genetic polymorphisms differential responses drugs.

参考文章(98)
David Borsook, Lino Becerra, Alexander Ploghaus, Utilizing brain imaging for analgesic drug development. Current opinion in investigational drugs. ,vol. 3, pp. 1342- ,(2002)
Patrick A. Turski, Ned H. Kalin, James A. Sorenson, Richard J. Davidson, Mark Lowe, William Irwin, Bryan J. Mock, Gemma Warner, Jennifer L. Orendi, Steve K. Sutton, Functional magnetic resonance imaging studies of emotional processing in normal and depressed patients : Effects of venlafaxine The Journal of Clinical Psychiatry. ,vol. 58, pp. 32- 39 ,(1997)
Jonathan Brooks, Irene Tracey, From nociception to pain perception: imaging the spinal and supraspinal pathways. Journal of Anatomy. ,vol. 207, pp. 19- 33 ,(2005) , 10.1111/J.1469-7580.2005.00428.X
David Borsook, Alexandre F. M. DaSilva, Alex Ploghaus, Lino Becerra, Specific and Somatotopic Functional Magnetic Resonance Imaging Activation in the Trigeminal Ganglion by Brush and Noxious Heat The Journal of Neuroscience. ,vol. 23, pp. 7897- 7903 ,(2003) , 10.1523/JNEUROSCI.23-21-07897.2003
A. F. Cohen, J. M. A. Van Gerven, S. J. De Visser, J. P. Van Der Post, P. P. De Waal, F. Cornet, Biomarkers for the effects of benzodiazepines in healthy volunteers. British Journal of Clinical Pharmacology. ,vol. 55, pp. 39- 50 ,(2003) , 10.1046/J.1365-2125.2002.T01-10-01714.X
P. J. Magistretti, Energy on Demand Science. ,vol. 283, pp. 496- 497 ,(1999) , 10.1126/SCIENCE.283.5401.496
Alexandre Façanha Marcelo da Silva, Somatotopic Activation in the Human Trigeminal Pain Pathway The Journal of Neuroscience. ,vol. 22, pp. 8183- 8192 ,(2002) , 10.1523/JNEUROSCI.22-18-08183.2002
P.J. Basser, J. Mattiello, D. LeBihan, MR diffusion tensor spectroscopy and imaging. Biophysical Journal. ,vol. 66, pp. 259- 267 ,(1994) , 10.1016/S0006-3495(94)80775-1
Gavin C Houston, Nikolas G Papadakis, T Adrian Carpenter, Laurance D Hall, Bhashkar Mukherjee, Michael F James, Christopher L-H Huang, None, Mapping of brain activation in response to pharmacological agents using fMRI in the rat. Magnetic Resonance Imaging. ,vol. 19, pp. 905- 919 ,(2001) , 10.1016/S0730-725X(01)00405-2